Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Ähnliche Einträge
Ähnliche Einträge
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
von: Claudia Crimi, et al.
Veröffentlicht: (2023-11-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
von: Carla Rognoni, et al.
Veröffentlicht: (2023-06-01) -
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
von: Paolo Solidoro, et al.
Veröffentlicht: (2022-01-01) -
Critical evaluation of asthma biomarkers in clinical practice
von: Giuseppe Guida, et al.
Veröffentlicht: (2022-10-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
von: Giorgio Walter Canonica, et al.
Veröffentlicht: (2020-08-01)